Noninvasive aesthetic procedures are continuously on the rise 1 and every year there is an increase in uptake of botulinum toxin as one of the most popular procedures performed in the United States and perhaps the world. In addition to the well-known anticholinergic effect (responsible for muscle-relaxation action), there is also increasing evidence of the antinociceptive effect, likely due to inhibition of neurogenic inflammation, 2 which is medicated by calcitonin gene-related peptide (CGRP), substance P, and blockade of local glutamate release that leads to local edema. 3 It is difficult to quantify the utilization of botulinum toxin for its therapeutic uses as currently there is no tracking method of this modality and one may be surprised that the therapeutic utilization maybe as high as the aesthetic market growth.
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The authors of this paper 4 have focused their animal study on a very specific problem, which includes whether myotomy alone can be beneficial in postoperative muscle weakness, as it relates to some of the facial procedures that are commonly performed. The study evaluated three animal groups: group A underwent myotomy of the Latissimus Dorsi muscle; group B underwent myotomy and injection of botulinum toxin A (BtxA) into the severed muscle; group C injection of BtxA alone. Clinically, rendering a particular muscle inactive with a myotomy and/or removal of a portion of the muscle has not always been successful. Even with placing interposition allo-or autografts, the results have been mixed and unpredictable. 5 One wonders why some of the results are so unpredictable and can this be more related to a particular surgical technique or does the muscle have the capability of regaining function? The authors of this study have histologically evaluated the muscle in all three groups and the only histological significance found between the three treated groups, was the increased fat infiltration of the myotomy + BtxA group. Even though this is the only histological significance in this healing muscle group, it can possibly have major clinical implications. Many clinical studies have shown the correlation of the fat infiltration into the skeletal muscle as a poor correlation of muscle function and progression and further loss of function. 6, 7 In a recent clinical study, the radiographic signs of muscle degeneration in patients with low back pain was evaluated and three principal signs of muscle degeneration were detected on imaging: decreased muscle size, decreased radiographic density, and increased fat deposits. 8 In this animal study the increased fat deposition in the myotomy and BtxA group, should serve as a significant finding that this muscle group will have the poorest function at the endpoint of the study. This histological finding directly correlates to the strength evaluation where the mechanical and pharmacological intervention showed a significant reduction in muscle power.
It is still not clear why myotomized muscles can regain function if no pharmacological intervention is performed concurrently. The power of scar contracture is always underestimated where the scar pulls the remaining tissue together, leading to some avenue for regrowth, and the interposition grafts placed during surgery can serve as an excellent host for possible regeneration. The lack of muscle fiber activity due to the anticholinergic effect of BtxA during the healing process of a traumatized muscle may play an important role in the long-term function of the muscle. Further clinical studies are needed to further understand this mechanism, but nevertheless its use in clinical practice can expand given some of our understanding of the pathophysiology of a healing muscle. On the other hand, where a muscle tendon must heal, the inactivity of the muscle is desired to allow for expeditious healing. The pharmacological transient relaxation of a muscle has been shown to be helpful in areas where muscle and tendon healing are needed. 9 In addition, injection of botulinum toxin A in a specific muscle group showed relaxation of the surrounding muscles. 10 It's role on scar formation is still not well understood but studies have shown improved scar after transient relaxation of the underlying muscle. 11 The role of botulinum toxin is expanding every year in aesthetic and therapeutic markets. There are many benefits of its use that have been well described. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] We believe that as more surgeons are innovative and understand the potential benefits of botulinum toxin, the more clinical applications will be identified. Even though many of these therapeutic treatments are "off label," the use and advantages cannot be overlooked. Unfortunately, industry will not be able to obtain an "on label" use of an existing FDA approved product for every clinical scenario, given the stringent government study requirements for an on-label approval. It will be up to every physician to describe the potential benefit of its use and have the patient consent to the procedure. One example is the rapidly expanding use of botulinum toxin in management of large hernias. 25 The idea of adjunctive injection of botulinum toxin A at time of myotomy is an applicable clinical idea. For facial procedures, preoperative botulinum toxin A injection can be beneficial in relaxing the muscle prior to the myotomy. Further clinical studies will be necessary to truly assess the benefit.
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